Treatment of Low-Lying Early Rectal Cancer

Video

This video examines the treatment of patients with low-lying rectal cancer and explores options such as neoadjuvant chemoradiotherapy, which could improve the efficacy of surgery.

In this video, Julio Garcia-Aguilar, MD, PhD, of Memorial Sloan Kettering Cancer Center in New York, discusses the treatment of patients with low-lying rectal cancer.

Garcia-Aguilar also highlights phase II trial that studied neoadjuvant chemoradiotherapy, with the goal of making local excision more effective, as well as the challenges of conducting trials in this type of cancer.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Epistemic closure, broad-scale distribution, and insurance companies are the 3 largest obstacles to implementing new peritoneal surface malignancy care guidelines into practice.
“This is something where this is written by the trainees, for the trainees, and, of course, for all the other clinicians who take care of patients,” said Kiran Turaga, MD, MPH.
“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.